Newsbenzinga
Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says
· Published
Article summary
Edwards Lifesciences tops Q2 Wall Street estimates with $1.74B in revenue. EW stock jumps as analysts see continued upside ahead.
An excerpt from the original article.
Comments —
Loading comments…